Acute treatment and long-term prognosis of severe protein-loss in atopic dermatitis (splad)

CONCLUSIONS: Even in patients with SPLAD, the most severe AD, TCS-use may be reduced to 2 days per week or less after 3 years with appropriate skin treatment.PMID:34911891 | DOI:10.15036/arerugi.70.1383
Source: Arerugi - Category: Allergy & Immunology Authors: Source Type: research